← Leaderboards
Karen R Rabin
Baylor College Of Medicine
$5,475,660
Attributed
$12,105,083
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2020–25$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,798,528 · 10
By mechanism
R01$7,540,538 · 3
P20$4,385,658 · 3
U54$3,227,463 · 3
U01$2,644,869 · 1
Top collaborators
- Philip Lupo12 shared
- Maria Monica Gramatges5 shared
- Lisa M Jacola5 shared
- Sandra W Ryeom2 shared
- A.J. Agopian1 shared
- Cynthia J. Guidos1 shared
- Sonja Ann Rasmussen1 shared
- Peter Alan Sims1 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Philip Lupo$9,426,109
- Austin L Brown$3,048,574
- Hugo J Bellen$42,403,967
- Lisa Schum Kahalley$10,210,510
- Melissa Anne Suter$1,235,409
Others in their field
Other Emerging Leaders on “Child”
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$29,616,650
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$28,898,304
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$25,473,113
- Beth Baseler · Leidos Biomedical Research, Inc.$22,470,677
- Gaurav J Dave · Duke University$17,082,764
Research focus
ChildAcute Lymphocytic LeukemiaBiologyAcute LeukemiaImproved OutcomeLeukemiaGeneticBiologicalEtiologyChildhood LeukemiaRisk FactorsToxic EffectSiteEnrollmentTreatment OutcomeCohortMortalityTreatment-Related ToxicityVulnerable PopulationsEthnic DisparityProgramsPediatric Oncology GroupCongenital AbnormalityAdolescent
Grant awards (19)
Reducing Disparities in Acute Leukemia (REDIAL) Consortium$2,494,110
U54 · FY2025 · CA
Chronic Health Conditions in Survivors of Down Syndrome-Associated Leukemia$676,350
R01 · FY2025 · CA
Core A: Administrative Core$620,649
U54 · FY2025 · CA · contact PI
Preventing Fatal Infections in Children with Down Syndrome During Treatment for Acute Lymphoblastic Leukemia$533,887
R01 · FY2025 · CA
Career Enhancement Program$112,704
U54 · FY2025 · CA · contact PI
Down Syndrome Early Childhood Omics, Deep Phenotyping, and Epidemiology in Texas: DECODE IT Cohort$2,644,869
U01 · FY2024 · HD
Molecular epidemiology of acute lymphoblastic leukemia in children with Down syndrome$801,780
R01 · FY2024 · CA · contact PI
Preventing Fatal Infections in Children with Down Syndrome During Treatment for Acute Lymphoblastic Leukemia$548,211
R01 · FY2024 · CA
Chronic Health Conditions in Survivors of Down Syndrome-Associated Leukemia$370,134
R01 · FY2024 · CA
Improving Outcome Disparities for Latino Children and Adolescents with Acute Lymphoblastic Leukemia$1,027,258
P20 · FY2023 · CA · contact PI
Molecular epidemiology of acute lymphoblastic leukemia in children with Down syndrome$843,979
R01 · FY2023 · CA · contact PI
Chronic Health Conditions in Survivors of Down Syndrome-Associated Leukemia$588,588
R01 · FY2023 · CA
Administrative Core$496,614
P20 · FY2023 · CA · contact PI
Improving Outcome Disparities for Latino Children and Adolescents with Acute Lymphoblastic Leukemia$1,049,211
P20 · FY2022 · CA · contact PI
Chronic Health Conditions in Survivors of Down Syndrome-Associated Leukemia$616,566
R01 · FY2022 · CA
Administrative Core$502,564
P20 · FY2022 · CA · contact PI
Improving Outcome Disparities for Latino Children and Adolescents with Acute Lymphoblastic Leukemia$1,122,866
P20 · FY2021 · CA · contact PI
Administrative Core$187,145
P20 · FY2021 · CA · contact PI
Molecular epidemiology of acute lymphoblastic leukemia in children with Down syndrome$2,561,043
R01 · FY2020 · CA · contact PI